Is there an association between non-alcoholic fatty liver disease and cognitive function? A systematic review
Open Access
- 11 January 2022
- journal article
- review article
- Published by Springer Nature in BMC Geriatrics
- Vol. 22 (1) , 1-19
Abstract
Background: Non-alcoholic fatty liver disease (NAFLD) is represented as the most common liver disease worldwide. NAFLD is associated with metabolic risk factors underpinned by insulin resistance, inflammation and endothelial dysfunction, leading to extrahepatic changes in central nervous diseases such as cognitive impairment, Alzheimer’s disease and dementia. The aim of the review is to explore the association between NAFLD and cognitive function. Methods: Using the PRISMA guidelines, a systematic electronic literature search was conducted in four databases: MEDLINE, PsychINFO, Embase and CINAHL from inception until March 2021. Neuropsychological tests utilised within each study were grouped into relevant cognitive domains including ‘general cognition’, ‘reasoning’, ‘mental speed, attention and psychomotor speed’, ‘memory and learning’, ‘language’, ‘visuospatial perception’ and ‘ideas, abstraction, figural creations and mental flexibility’. Results: Eleven observational studies that involved 7978 participants with a mean age of 51 years were included. Those with NAFLD had poor cognitive performance in three cognitive domains, including ‘general cognition’, ‘mental speed, attention and psychomotor speed’, and ‘ideas, abstraction, figural creations and mental flexibility’. Conclusion: The observed results from the 11 included studies showed that NAFLD was associated with lower cognitive performance across several domains. However, studies conducted to date are limited to observational designs and are heterogeneous with varying diagnostic tools used to assess cognitive function. Trial registration: PROSPERO Registration: CRD42020161640.Keywords
This publication has 47 references indexed in Scilit:
- Prevalences of dementia and cognitive impairment among older people in sub-Saharan Africa: a systematic reviewBulletin of the World Health Organization, 2013
- Impact of Metabolic Syndrome on Cognition and BrainArteriosclerosis, Thrombosis, and Vascular Biology, 2012
- The Metabolic Syndrome and Cognitive Performance: The Northern Manhattan StudyNeuroepidemiology, 2011
- Selective review of cognitive agingJournal of the International Neuropsychological Society, 2010
- IL-6 and IL-18 in Blood May Discriminate Cirrhotic Patients With and Without Minimal Hepatic EncephalopathyJournal of Clinical Gastroenterology, 2009
- Liver disease as a risk factor for cognitive decline and dementia: An Under-recognized issue #Hepatology, 2009
- Metabolic Syndrome and Risk for Incident Alzheimer's Disease or Vascular DementiaDiabetes Care, 2009
- Cognition in liver diseaseLiver International, 2005
- Prevalence of Hepatic Steatosis in An Urban Population in the United States: Impact of EthnicityHepatology, 2004
- Memory Impairments Concomitant with Nonalcoholic CirrhosisInternational Journal of Neuroscience, 1987